PACIRA BIOSCIENCES, INC. Cost of Goods Sold (Deprecated 2018-01-31)
PACIRA BIOSCIENCES, INC. (PCRX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $54.77 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-25.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2014-02-25
- PACIRA BIOSCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $54.77M, a 72.54% increase from fiscal 2012.
- PACIRA BIOSCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $31.74M, a 107.34% increase from fiscal 2011.
- PACIRA BIOSCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $15.31M, a 34.61% increase from fiscal 2010.
- PACIRA BIOSCIENCES, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2010 was $11.37M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|
| 2013-12-31 | $54.77M 10-K · filed 2014-02-25 |
| 2012-12-31 | $31.74M 10-K · filed 2014-02-25 |
| 2011-12-31 | $15.31M 10-K · filed 2014-02-25 |
| 2010-12-31 | $11.37M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |